Pharmacy
Home Pharmacy
ADA: Vitamin D Supplementation Does Not Lower T2DM Risk
No significant difference in risk for type 2 diabetes seen for those receiving vitamin D, placebo
Testicular Cancer Treatment Does Not Up Risk for Offspring Birth Defects
No increased risk seen at posttreatment in children of fathers with testicular germ-cell cancer
Dietary Supplements May Up Risk for Severe Medical Events
Increased risk seen in association with supplements sold for muscle building, energy, weight loss
ASCO: Enzalutamide Beneficial in Metastatic Prostate Cancer
Progression-free, overall survival longer for men with metastatic, hormone-sensitive prostate cancer
Emgality Receives First FDA Approval for Treating Cluster Headache
Patients treated with Emgality had 8.7 fewer cluster headache attacks at 3.0 weeks versus 5.2 with placebo
App Helps Pediatric Asthma Patients, Parents Self-Monitor
With one year of use, improvements seen in asthma outcomes
ASCO: Olaparib Beats Placebo for BRCA-Related Pancreatic Cancer
Progression-free survival significantly improved with olaparib versus placebo for metastatic disease
Common Supplement Ingredient Could Harm Fetus, FDA Warns
Vinpocetine is a man-made compound used in some products sold as dietary supplements
Immunizations Up in California After Repeal of Nonmedical Exemptions
At the same time, there was a sharp increase in medical exemptions in a few California counties
β-Blockers May Moderate Impact of Stress on Atrial Fibrillation
Likelihood of atrial fibrillation episode up during anger or stress; β-blockers can attenuate effect
